Cargando…

Commentary: Janus kinase inhibitors and their use in autoimmune ocular inflammatory disorders

Detalles Bibliográficos
Autor principal:	Moreker, Mayur R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2020
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7690464/ https://www.ncbi.nlm.nih.gov/pubmed/32823422 http://dx.doi.org/10.4103/ijo.IJO_1656_20

Ejemplares similares

Commentary: Behçet’s uveitis – Expanding treatment horizons
por: Moreker, Mayur R
Publicado: (2023)

Role of Janus Kinase (JAK) Inhibitor in Autoimmune Ocular Inflammation: A Systematic Review
por: Wen, Ji, et al.
Publicado: (2021)

Janus kinase inhibitors in autoimmune bullous diseases
por: Huang, Dawei, et al.
Publicado: (2023)

Translational Positioning of Janus Kinase (JAK) Inhibitors in Alopecia Areata
por: Blume-Peytavi, Ulrike, et al.
Publicado: (2015)

Commentary: Systemic immune-inflammatory indices and their association with ocular disorders—Do we have economical and reliable biomarkers?
por: Madanagopalan, V G
Publicado: (2020)

The Future of Janus Kinase Inhibitors in Inflammatory Bowel Disease
por: De Vries, L.C.S., et al.
Publicado: (2017)

Safety of Janus Kinase Inhibitors in Inflammatory Bowel Diseases
por: Núñez, Paulina, et al.
Publicado: (2023)

Commentary: Ocular endoscopy: An eye into the eye
por: Bhende, Muna, et al.
Publicado: (2021)

Commentary: Posterior subtenon triamcinolone - The unsung hero for managing various ocular disorders
por: Tripathy, Koushik
Publicado: (2023)

Kinase inhibitors for the treatment of inflammatory and autoimmune disorders
por: Bhagwat, Shripad S.
Publicado: (2008)

Itch and Janus Kinase Inhibitors
por: HAN, Yujin, et al.
Publicado: (2023)

Clinical Pharmacology of Janus Kinase Inhibitors in Inflammatory Bowel Disease
por: Lefevre, Pavine L C, et al.
Publicado: (2020)

The Era of Janus Kinase Inhibitors for Inflammatory Bowel Disease Treatment
por: Kim, Jin-Woo, et al.
Publicado: (2021)

Commentary: Assessment of limbal ischemia in ocular burns
por: Radhakrishnan, Naveen, et al.
Publicado: (2019)

Commentary: Effect of exercise on ocular blood flow
por: Ratra, Dhanashree, et al.
Publicado: (2021)

Commentary: Demodex – Microscopic residents of the ocular biome
por: Singh, Aastha, et al.
Publicado: (2021)

Commentary: Waardenburg syndrome: Genetics and ocular features
por: Chakraborty, Koyel, et al.
Publicado: (2022)

Commentary: Evaluating ocular surface disease in glaucoma
por: Behera, Geeta, et al.
Publicado: (2022)

Commentary: Ocular myasthenia gravis: Interpreting the investigations
por: Nair, Akshay Gopinathan
Publicado: (2022)

Targeting the Janus Kinase Family in Autoimmune Skin Diseases
por: Howell, Michael D., et al.
Publicado: (2019)

Commentary: Dematiaceous fungal keratitis: Importance of ocular microbiology
por: Joseph, Joveeta
Publicado: (2019)

Commentary: Impact of COVID-19 on ocular surface health
por: Singh, Aastha, et al.
Publicado: (2021)

Commentary: Importance of ocular imaging in macular serpiginous choroiditis
por: Venkatesh, Ramesh, et al.
Publicado: (2022)

Commentary: Ocular biometry in a developing country’s perspective
por: Nayak, Bhagabat, et al.
Publicado: (2022)

Commentary: Ocular lesions in leprosy – Should we forget?
por: Biswas, Jyotirmay, et al.
Publicado: (2022)

Commentary: Meibomian gland dysfunction and ocular surface analysis
por: Dave, Abhishek
Publicado: (2022)

Commentary: Exercise, intraocular pressure, and ocular blood flow
por: Sathi Devi, A V
Publicado: (2022)

Janus Kinase inhibitors in the New Treatment Paradigms of Inflammatory Bowel Disease
por: Siegmund, Britta
Publicado: (2020)

The opposite impact of Janus kinase inhibitor Ruxolitinib on the function of bone marrow mesenchymal stem cells and immune cells in acute GVHD recipients
por: Zeng, Defu
Publicado: (2023)

Janus kinase inhibitors: jackpot or potluck?
por: Pavithran, Keechilat, et al.
Publicado: (2012)

Janus Kinase Inhibitors and Cell Therapy
por: Assal, Amer, et al.
Publicado: (2021)

Commentary: Exploring the transmission of COVID-19 through the ocular surface
por: Joseph, Joveeta
Publicado: (2020)

Commentary: Ocular toxoplasma: From bench-side to clinical practice!
por: Murugan, S Bala
Publicado: (2018)

Commentary: Ocular changes after bariatric surgery - An evolving domain
por: Sheth, Jay U
Publicado: (2021)

Commentary: Ocular hypertension after Descemet’s stripping endothelial keratoplasty
por: Sridhar, Uma, et al.
Publicado: (2022)

Commentary: Artificial intelligence and machine learning in ocular oncology: Retinoblastoma
por: Gopal, Lingam
Publicado: (2023)

More Unnecessary Imaginary Worlds - Part 1: The Institute for Clinical and Economic Review’s Evidence Report on Janus Kinase (JAK) Inhibitors in Rheumatoid Arthritis
por: Langley, Paul C
Publicado: (2020)

Acneiform Lesions but not Acne after Treatment with Janus Kinase Inhibitors: Diagnosis and Management of Janus Kinase-acne
por: BALLANGER, Fabienne, et al.
Publicado: (2023)

Commentary: Ocular graft versus host disease: Need for multidisciplinary care
por: Shanbhag, Swapna S, et al.
Publicado: (2021)

Commentary: Importance of ocular and systemic examination among state bus drivers
por: Morya, Arvind K, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_h813knof378bve7mqfu8jta3ri